Elevance Health
737 hedge funds and large institutions have $29.4B invested in Elevance Health in 2016 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 269 increasing their positions, 290 reducing their positions, and 70 closing their positions.
31% more funds holding in top 10
Funds holding in top 10: 16 → 21 (+5)
7% less repeat investments, than reductions
Existing positions increased: 269 | Existing positions reduced: 290
1.17% less ownership
Funds ownership: 90.62% → 89.46% (-1.2%)
3% less funds holding
Funds holding: 761 → 737 (-24)
6% less capital invested
Capital invested by funds: $31.3B → $29.4B (-$1.88B)
19% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 70
32% less call options, than puts
Call options by funds: $122M | Put options by funds: $181M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$211M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$164M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$160M |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$153M |
| 5 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
+$124M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$747M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$238M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$180M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$120M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$116M |
ELV Hedge Fund Activity: Q3 2016 in Review
737 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2016, worth a combined $29.4B — down 6% from $31.3B a quarter earlier.
Sellers outnumbered buyers: 70 funds closed out of ELV and 57 opened new positions — a net loss of 13 holders — while 290 trimmed existing stakes and 269 added.
The largest buyer was Glenview Capital Management, adding an estimated $211M. The largest seller was T. Rowe Price Associates, cutting an estimated $747M.
- 737 institutional investors held Elevance Health (ELV) as of Q3 2016, down from 761 in Q2 2016.
- Funds reported $29.4B of Elevance Health stock for Q3 2016, down 6% quarter-over-quarter.
- 57 funds opened new Elevance Health positions in Q3 2016 and 70 closed out, a net change of -13 holders.
- The largest Elevance Health buyer in Q3 2016 was Glenview Capital Management, an estimated $211M added.
- The largest Elevance Health seller in Q3 2016 was T. Rowe Price Associates, an estimated $747M sold.
Based on aggregated 13F filings for Q3 2016.